Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Dec 01, 2021 5:25pm
163 Views
Post# 34187351

Todays House Positions

Todays House Positions
House Positions for C:ARCH from 20211201 to 20211201
House Bought $Val Ave Sold $Val Ave Net $Net
7 TD Sec 33,153 165,892 5.004 2,987 15,012 5.026 30,166 -150,880
22 Fidelity 29,000 144,074 4.968 700 3,682 5.26 28,300 -140,392
80 National Bank 10,225 52,158 5.101 1,526 7,626 4.997 8,699 -44,532
2 RBC 9,566 48,021 5.02 7,539 37,758 5.008 2,027 -10,263
124 Questrade 2,090 10,347 4.951 160 809 5.056 1,930 -9,538
14 ITG 1,977 9,901 5.008 457 2,291 5.013 1,520 -7,610
13 Instinet 1,000 4,970 4.97 0   1,000 -4,970
28 BBS 950 4,786 5.038 0   950 -4,786
72 Credit Suisse 100 496 4.96 0   100 -496
53 Morgan Stanley 7 36 5.143 0   7 -36
39 Merrill Lynch 100 490 4.90 100 489 4.89 0 -1
19 Desjardins 1,050 5,427 5.169 1,050 5,300 5.048 0 -127
84 Ind Trading 3 14 4.667 92 472 5.13 -89 458
83 Mackie 0   170 875 5.147 -170 875
68 Leede 437 2,195 5.023 640 3,209 5.014 -203 1,014
33 Canaccord 2,500 12,297 4.919 2,800 13,851 4.947 -300 1,554
57 Interactive 100 489 4.89 400 1,968 4.92 -300 1,479
88 Credential 500 2,525 5.05 1,000 4,970 4.97 -500 2,445
74 GMP 0   750 3,836 5.115 -750 3,836
79 CIBC 7,535 37,993 5.042 9,515 48,276 5.074 -1,980 10,283
59 PI 0   2,500 12,500 5.00 -2,500 12,500
9 BMO Nesbitt 10,004 50,422 5.04 15,250 76,235 4.999 -5,246 25,813
85 Scotia 3,375 17,073 5.059 10,150 50,743 4.999 -6,775 33,670
62 Haywood 0   10,000 49,175 4.918 -10,000 49,175
1 Anonymous 44,914 224,576 5.00 90,800 455,108 5.012 -45,886 230,532
TOTAL 158,586 794,182 5.008 158,586 794,185 5.008 0 3
 

<< Previous
Bullboard Posts
Next >>